Abstract:Objectives: To assess whether HIV infection directly or indirectly promotes coronary artery disease (CAD) volume progression in a longitudinal study of African Americans. Methods: We randomly selected 300 individuals with subclinical CAD (210 male; age: 48.0 ± 7.2 years; 226 HIV infected, 174 cocaine users) from 1429 cardiovascularly asymptomatic participants of a prospective epidemiological study between May 2004 and August 2015. Individuals underwent coronary CT angiography at two time points (mean follow-up: 4.0 ± 2.3 years). We quantified noncalcified (NCP: -100-350HU), low-attenuation noncalcified (LA-NCP: -100-30HU), and calcified (CP: ≥ 351 HU) plaque volumes. Linear mixed models were used to assess the effects of HIV infection, atherosclerotic cardiovascular disease (ASCVD) risk, and years of cocaine use on plaque volumes. Results: There was no significant difference in annual progression rates between HIV-infected and HIV-uninfected regarding NCP (8.7 [IQR: 3.0-19.4] mm3/year vs. 4.9 [IQR: 1.5-18.3] mm3/year, p = 0.14), LA-NCP (0.2 [IQR: 0.0-1.6] mm3/year vs. 0.2 [IQR: 0.0-0.9] mm3/year, p = 0.07) or CP volumes (0.3 [IQR: 0.0-3.4] mm3/year vs. 0.1 [IQR: 0.0-3.2] mm3/year, p = 0.30). Multivariately, HIV infection was not associated with NCP (-6.9mm3, CI: [-32.8-19.0], p = 0.60), LA-NCP (-0.1mm3, CI: [-2.6-2.4], p = 0.92), or CP volumes (-0.3mm3, CI: [-9.3-8.6], p = 0.96). However, each percentage of ASCVD and each year of cocaine use significantly increased total, NCP, and CP volumes among HIV-infected individuals, but not among HIV-uninfected. Importantly, none of the HIV-associated medications had any effect on plaque volumes (p > 0.05 for all). Conclusions: The more profound adverse effect of risk factors in HIV-infected individuals may explain the accelerated progression of CAD in these people, as HIV infection was not independently associated with any coronary plaque volume. Key points: • Human immunodeficiency virus-infected individuals may have similar subclinical coronary artery disease, as the infection is not independently associated with coronary plaque volumes. • However, cardiovascular risk factors and illicit drug use may have a more profound effect on atherosclerosis progression in those with human immunodeficiency virus infection, which may explain the accelerated progression of CAD in these people. • Nevertheless, through rigorous prevention and abstinence from illicit drugs, these individuals may experience similar cardiovascular outcomes as -uninfected individuals.

18O proteomics reveal increased human apolipoprotein CIII in Hispanic HIV-1+ women with HAART that use cocaine

Frequent Cocaine Use is Associated With Larger HIV Latent Reservoir Size

Impact of Cocaine Use on Protease Inhibitor-Associated Dyslipidemia in HIV-infected Adults

Cocaine Use May Modify HIV/ART-associated Myocardial Steatosis and Hepatic Steatosis.

Human Immunodeficiency Virus 1 Infection, Cocaine, and Coronary Calcification

Gene expression differences in differentially methylated sites associated with HIV status and cocaine use

High-risk Coronary Plaque Regression in Cash-based Contingency Management Intervention among Cocaine Users with HIV-associated Subclinical Coronary Atherosclerosis

HIV Infection and Cocaine Use Induce Endothelial Damage and Dysfunction in African Americans

Cocaine Use Modifies the Association Between Antiretroviral Therapy and Endothelial Dysfunction among Adults with HIV Infection

Cocaine Use May Moderate the Associations of HIV and Female Sex with Neurocognitive Impairment in a Predominantly African American Population Disproportionately Impacted by HIV and Substance Use.

Long-Term Cocaine Use And Antiretroviral Therapy Are Associated With Silent Coronary Artery Disease In African Americans With Hiv Infection Who Have No Cardiovascular Symptoms

Analysis of Sigma-1 Receptor Antagonist BD1047 Effect on Upregulating Proteins in HIV-1-Infected Macrophages Exposed to Cocaine Using Quantitative Proteomics

Cocaine Abstinence And Reduced Use Associated With Lowered Marker Of Endothelial Dysfunction In African Americans: A Preliminary Study

Cocaine and HIV-1 Interplay: Molecular Mechanisms of Action and Addiction

Impaired extinction of cocaine seeking in HIV-infected mice is accompanied by peripheral and central immune dysregulation

Hiv Infection Itself May Not Be Associated with Subclinical Coronary Artery Disease among African Americans Without Cardiovascular Symptoms

Vitamin D Deficiency is Associated with Development of Subclinical Coronary Artery Disease in HIV-infected African American Cocaine Users with Low Framingham-defined Cardiovascular Risk

Long-term cocaine use is associated with increased coronary plaque burden - a pilot study

Positive allosteric modulators of the serotonin 2C receptor as novel therapeutics for cocaine use disorder

Cardiovascular risk factors and illicit drug use may have a more profound effect on coronary atherosclerosis progression in people living with HIV